fbpx
Request Info
Resources|Resource Type|Publications|Inhibition of Hsp27 Radiosensitizes Head-and-Neck Cancer by Modulating Deoxyribonucleic Acid Repair.

Inhibition of Hsp27 Radiosensitizes Head-and-Neck Cancer by Modulating Deoxyribonucleic Acid Repair.

September 1, 2013

To present a novel method of tumor radiosensitization through Hsp27 knockdown using locked nucleic acid (LNA) and to investigate the role of Hsp27 in DNA double strand break (DSB) repair.

David M. Guttmann, Lori Hart, Kevin Du, Andrew Seletsky, Constantinos Koumenis

Download Paper

Contact Us

Find out more about why Xstrahl will work tirelessly for you

Contact Us

Explore Related Posts

CIX3 used in HER2-positive Tumor Research

CIX3 used in HER2-positive Tumor Research

See what researchers found in the recent study: Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a  metastatic model of HER2‑positive murine tumor. See the original publication here.

read more
Review of Low-Dose RT for Osteoarthritis

Review of Low-Dose RT for Osteoarthritis

Despite its clinical use and investigation in other countries, low dose radiotherapy (LDRT) in the treatment of osteoarthritis (OA) is minimally used in the United States (US). Numerous recent studies published outside the US have shown moderate to long-term pain...

read more
SARRP Used in Melanoma Vaccination Study

SARRP Used in Melanoma Vaccination Study

In a recent study, Short-course neoadjuvant in situ vaccination for murine melanoma, researchers compared the effectiveness of neoadjuvant radiotherapy and/or tumor vaccination. See more below and the full study here.

read more